News
The FDA has granted Mesoblast’s stem cell therapy, Ryoncil (remestemcel-L), seven years of orphan drug exclusivity for the ...
SurvivorNet on MSN21h
Enhertu: A Targeted Treatment Provides Hope For Difficult-To-Treat Lung CancerTrastuzumab deruxtecan belongs to a group of antineoplastic drugs known as antibody-drug conjugates (ADCs). This type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback